企業プロフィール
Avidity Biosciences 株価・ニュース・カタリスト
- ティッカー:
- RNA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
12.96 USD (+0.93%)
終値
最終更新: 2026年8月17日
210M USD
時価総額
株価変動の要因
As of Aug 17, 2026, RNA closed up 0.93% at $12.96. No new same-company headline was identified in the current news window.
企業概要
事業概要
Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform. Its story is built around targeted RNA delivery and disease-specific programs.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Avidity sits in advanced biotechnology.
ビジネスモデルの特徴
The company depends on platform validation, clinical data, and the promise of targeted RNA delivery to hard-to-reach tissues.
バイオ業界での位置付け
Avidity is one of the most interesting RNA-delivery names because platform success could unlock multiple disease areas.
今後のカタリスト
- Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform. The market will care about whether the platform keeps producing convincing in-human signals.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。